BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1139 related articles for article (PubMed ID: 19861459)

  • 1. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
    Dang CV; Le A; Gao P
    Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay between MYC and HIF in the Warburg effect.
    Dang CV
    Ernst Schering Found Symp Proc; 2007; (4):35-53. PubMed ID: 18811052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.
    Dang CV
    Cancer Res; 2010 Feb; 70(3):859-62. PubMed ID: 20086171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC, microRNAs and glutamine addiction in cancers.
    Dang CV
    Cell Cycle; 2009 Oct; 8(20):3243-5. PubMed ID: 19806017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC, metabolism, cell growth, and tumorigenesis.
    Dang CV
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.
    Gao P; Tchernyshyov I; Chang TC; Lee YS; Kita K; Ochi T; Zeller KI; De Marzo AM; Van Eyk JE; Mendell JT; Dang CV
    Nature; 2009 Apr; 458(7239):762-5. PubMed ID: 19219026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism.
    Dang CV
    Cold Spring Harb Symp Quant Biol; 2011; 76():369-74. PubMed ID: 21960526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring MYC-Mediated Metabolism in Tumorigenesis.
    Tang HY; Goldman AR; Zhang X; Speicher DW; Dang CV
    Methods Mol Biol; 2021; 2318():231-239. PubMed ID: 34019293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1.
    Kim JW; Gao P; Liu YC; Semenza GL; Dang CV
    Mol Cell Biol; 2007 Nov; 27(21):7381-93. PubMed ID: 17785433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.
    Pérez-Escuredo J; Dadhich RK; Dhup S; Cacace A; Van Hée VF; De Saedeleer CJ; Sboarina M; Rodriguez F; Fontenille MJ; Brisson L; Porporato PE; Sonveaux P
    Cell Cycle; 2016; 15(1):72-83. PubMed ID: 26636483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC on the path to cancer.
    Dang CV
    Cell; 2012 Mar; 149(1):22-35. PubMed ID: 22464321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of glycolysis and the Warburg effect by estrogen-related receptors.
    Cai Q; Lin T; Kamarajugadda S; Lu J
    Oncogene; 2013 Apr; 32(16):2079-86. PubMed ID: 22665055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.
    Wise DR; DeBerardinis RJ; Mancuso A; Sayed N; Zhang XY; Pfeiffer HK; Nissim I; Daikhin E; Yudkoff M; McMahon SB; Thompson CB
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18782-7. PubMed ID: 19033189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon source metabolism and its regulation in cancer cells.
    Yin C; Qie S; Sang N
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):17-35. PubMed ID: 22339657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells.
    Kleszcz R; Paluszczak J; Krajka-Kuźniak V; Baer-Dubowska W
    Adv Clin Exp Med; 2018 Jun; 27(6):735-742. PubMed ID: 29790697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC, Metabolism, and Cancer.
    Stine ZE; Walton ZE; Altman BJ; Hsieh AL; Dang CV
    Cancer Discov; 2015 Oct; 5(10):1024-39. PubMed ID: 26382145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Time for MYC: Metabolism and Therapy.
    Dang CV
    Cold Spring Harb Symp Quant Biol; 2016; 81():79-83. PubMed ID: 28174256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
    Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
    Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.